European Regulatory Watch

Latest News


Milmo_Sean-842441-1408522438877.jpg

The rising incidence of medicine defects and shortages stemming from sub-standard manufacturing is forcing Europe to give higher prominence to more effective inspections procedures.

Milmo_Sean-830509-1408530277657.jpg

The European Union is strengthening its pioneering role in the regulation of biosimilars by further developing the basic rules for determining the levels of compatibility for this group of drugs. There are, however, some key issues that are not easy to resolve, as evident in a recent workshop on biosimilars organized by the European Medicines Agency (EMA).

Milmo_Sean-817421-1408540256073.jpg

European governments are under pressure to take regulatory action, but solving the problem of medicine shortages is not as straightforward as it seems.

Milmo_Sean-814889-1416906172763.jpg

A science- and risk-based approach to verify and demonstrate that a process operating within predefined specified parameters consistently produces material that meets all its critical quality attributes.